Rare earth orthoferrite LnFeO3 nanoparticles for bioimaging

September 4, 2018, Wiley
Rare earth orthoferrite LnFeO3 nanoparticles for bioimaging
Credit: Wiley

Magnetic resonance imaging (MRI) has emerged as one of the most powerful clinical imaging tools because of its superb spatial resolution and soft tissue contrast, especially when using contrast agents. In the European Journal of Inorganic Chemistry, scientists have presented a new kind of nanoparticle contrast agent combining two contrast agent classes – iron oxide and rare earth metal ions – into one chemical compound. These rare earth orthoferrites were obtained in a sol-gel process followed by autocombustion.

During an MRI scan, the patient is pushed into a "tube" in which there is a . This directs the nuclear spin of the hydrogen atoms in the water molecules in the patient's tissues. When an alternating magnetic field is superimposed, it "shoves" some of the spins out of the preferred orientation so that they synchronously "spin". Once the alternating field is turned off, the spins return to their preferred orientation and lose their synchronicity. The times it takes for these two processes, referred to as T1 and T2 relaxation times, can be observed separately. These times depend on the environment of the spin, allowing for differentiation between tissues with different properties, such as tumors.

The between normal and diseased tissues can be dramatically improved by the use of , which influence the . Paramagnetic compounds of rare earth metals such as gadolinium (Gd) shorten T1-relaxation times; whereas superparamagnetic iron oxide based nanoparticles act as T2-shortening agents. There is a strong interest in developing novel nanoparticle based contrast agents with enhanced T1-T2 bimodal relaxation properties. Core-shell particles and with embedded Gd2O3 clusters are such agents.

Nanoparticles made of iron and ions interconnected into single chemical compounds, known as rare earth orthoferrites, offer a promising alternative. Yet the synthesis of the specific orthoferrite phases is very challenging, since undesired phases with different compositions can co-exist. Scientists from the Universities of Aveiro and of Coimbra (Portugal), and of the CNRS, Université Bordeaux (Pessac, France) have now developed a new approach to preparing monophasic nanosized orthoferrites LnFeO3 (Ln = europium, terbium, and gadolinium).

The method is based on a sol-gel / auto-combustion method: The precursors are dissolved in nitric/citric acid and this "sol" is heated at 200 °C to give a porous dry "gel". The gel is treated with a flame until it burns completely into a loose powder (autocombustion). It is then heated and milled twice and finally calcinated at 800 °C. The powders were characterized as the desired orthoferrites, exhibiting a perovskite-type crystal structure. Their magnetic behavior was found to result from the contribution of two magnetic sub-lattices: an antiferromagnetic lattice with the spins coupled through a Fe3+–O2–Fe3+ super exchange mechanism, and a paramagnetic contribution from noncoupled Ln3+ ions. In aqueous dispersions, no significant leaching of Ln3+ ions was observed. This minimizes their toxicity. Cultured Hela cells internalized the nanoparticles quickly. No cytotoxicity was observed.

The teams led by Marie-Hélène Delville and Carlos F.G.C. Geraldes expect that these characteristics mark their orthoferrites as potentially useful T2-weighed MRI contrast agents for further biomedical applications.

Explore further: Better contrast agents based on nanoparticles

More information: Sonia L. C. Pinho et al. Synthesis and Characterization of Rare-Earth Orthoferrite LnFeO3 Nanoparticles for Bioimaging, European Journal of Inorganic Chemistry (2018). DOI: 10.1002/ejic.201800468

Related Stories

Better contrast agents based on nanoparticles

August 3, 2016

Scientists at the University of Basel have developed nanoparticles which can serve as efficient contrast agents for magnetic resonance imaging. This new type of nanoparticles produce around ten times more contrast than the ...

Reimagining MRI contrast: Iron outperforms gadolinium

August 22, 2018

Rice University nanoscientists have demonstrated a method for loading iron inside nanoparticles to create MRI contrast agents that outperform gadolinium chelates, the mainstay contrast agent that is facing increased scrutiny ...

New Nanoparticle Structure Boosts Magnetic Properties

December 19, 2005

Magnetic nanoparticles have shown promise as contrast-enhancing agents for improving cancer detection using magnetic resonance imaging (MRI), as miniaturized heaters capable of killing malignant cells, and as targeted drug ...

New MRI contrast agent tested on big animals

July 31, 2017

The top causes of death worldwide, ischemic heart diseases and stroke, together with another major source of illness, that is cancer, require proper imaging of blood vessels. A team formed by the Center for Nanoparticle Research, ...

Recommended for you

Using machine learning to design peptides

December 10, 2018

Scientists and engineers have long been interested in synthesizing peptides—chains of amino acids responsible for conducting many functions within cells—to both mimic nature and to perform new activities. A designed peptide, ...

Biomimetic strategy leads to strong, recyclable rubber

December 10, 2018

Inspired by nature, Chinese scientists have produced a synthetic analogue to vulcanized natural rubber. Their material is just as tough and durable as the original. In the journal Angewandte Chemie, they reveal the secret ...

Custom-made artificial mother-of-pearl

December 10, 2018

Natural mother-of-pearl, such as mussels, is one of the hardest, most stable and stiff natural materials. Researchers have always been fascinated by it. The structure of mother-of-pearl is exquisite under the electron microscope; ...

Engineers repurpose wasp venom as an antibiotic drug

December 7, 2018

The venom of insects such as wasps and bees is full of compounds that can kill bacteria. Unfortunately, many of these compounds are also toxic for humans, making it impossible to use them as antibiotic drugs.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.